Skip to content

SCB SURGERY: what changed

BE 0740.497.406Other company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€101,021
2024 · €70,208+€30,814
Equity
€5,000
2024 · €75,208-€70,208
Cash
€63,527
2024 · €21,270+€42,257
Balance sheet total
€117,672
2024 · €77,152+€40,519

Largest movements

2024 to 2025
Assets
  • Cash +€42,257

    up €42,257 (+199%), from €21,270 to €63,527

    mainly Net result for the year (+€101,021) and Other debts (+€101,021)

  • Deferred charges and accrued income -€3,083

    down €3,083 (-10.7%), from €28,813 to €25,730

  • Tangible fixed assets +€1,923

    up €1,923 (+31.7%), from €6,070 to €7,993

    of which Furniture and vehicles: +€2,154

Equity and liabilities
  • Other debts +€101,021

    first reported in 2025, at €101,021

  • Profit (loss) carried forward -€70,208

    no longer reported in 2025; in 2024 it stood at €70,208

  • Tax, wage and social debts +€8,961

    up €8,961 (+936%), from €957 to €9,918

Income statement
  • Gross operating margin +€24,739

    up €24,739 (+22.9%), from €108,094 to €132,833

  • Depreciation -€15,950

    down €15,950 (-90.1%), from €17,699 to €1,748

  • Taxes +€10,712

    up €10,712 (+55.8%), from €19,206 to €29,918

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result.

Result 2024 €70,208
Gross operating margin +€24,739
Depreciation +€15,950
Other operating charges +€697
Financial income +€0
Financial charges +€140
Taxes -€10,712
Result 2025 €101,021
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€217,158
Investment -€3,671
Financing -€171,229
Cash 2024 €21,270
Net result for the year +€101,021
Depreciation +€1,748
Receivables within one year +€578
Deferred charges and accrued income +€3,083
Trade debts +€745
Tax, wage and social debts +€8,961
Other debts +€101,021
Investment in fixed assets (net) -€3,671
Contributions, distributions and other -€171,229
Cash 2025 €63,527
brings cash intakes cash out
Every line side by side 34 lines
Line Code 2024 2025 Change %
Total assets 20/58 €77,152 €117,672 +€40,519 +52.5%
Fixed assets 21/28 €6,070 €7,993 +€1,923 +31.7%
Tangible fixed assets 22/27 €6,070 €7,993 +€1,923 +31.7%
Plant, machinery and equipment 23 €5,405 €5,173 -€232 -4.3%
Furniture and vehicles 24 €665 €2,820 +€2,154 +324%
Current assets 29/58 €71,082 €109,679 +€38,597 +54.3%
Amounts receivable within one year 40/41 €20,999 €20,421 -€578 -2.8%
Trade receivables 40 €315 €588 +€273 +86.7%
Other amounts receivable 41 €20,684 €19,833 -€851 -4.1%
Cash at bank and in hand 54/58 €21,270 €63,527 +€42,257 +199%
Deferred charges and accrued income 490/1 €28,813 €25,730 -€3,083 -10.7%
Total equity and liabilities 10/49 €77,152 €117,672 +€40,519 +52.5%
Equity 10/15 €75,208 €5,000 -€70,208 -93.4%
Contributions 10/11 €5,000 €5,000 = 0.0%
Profit (loss) carried forward 14 €70,208 - -€70,208
Amounts payable 17/49 €1,944 €112,672 +€110,727 +5,695%
Amounts payable within one year 42/48 €1,944 €112,672 +€110,727 +5,695%
Trade debts 44 €987 €1,732 +€745 +75.5%
Suppliers 440/4 €987 €1,732 +€745 +75.5%
Taxes, remuneration and social security 45 €957 €9,918 +€8,961 +936%
Taxes 450/3 €957 €9,918 +€8,961 +936%
Other amounts payable 47/48 - €101,021 +€101,021
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €17,699 €1,748 -€15,950 -90.1%
Other operating charges 640/8 €772 €75 -€697 -90.3%
Gross operating margin 9900 €108,094 €132,833 +€24,739 +22.9%
Operating profit (loss) 9901 €89,623 €131,009 +€41,386 +46.2%
Financial income 75/76B - €0 +€0
Recurring financial income 75 - €0 +€0
Financial charges 65/66B €210 €70 -€140 -66.6%
Recurring financial charges 65 €210 €70 -€140 -66.6%
Profit (loss) for the period before taxes 9903 €89,414 €130,939 +€41,526 +46.4%
Income taxes 67/77 €19,206 €29,918 +€10,712 +55.8%
Profit (loss) for the period 9904 €70,208 €101,021 +€30,814 +43.9%
Profit (loss) for the period to be appropriated 9905 €70,208 €101,021 +€30,814 +43.9%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Value of the equity

Indication, not a valuation or advice
€256,064 to €357,490

Midpoint €298,325 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate. Change the assumptions and the value follows.

Adjusted equity €5,000
Capitalised earnings €507,129 to €709,980
Indication €256,064 to €357,490

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€5,000
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€5,000

Capitalised earnings

net result for the year (9904)
2025
€101,021
2024
€70,208
2023
€41,764
2022
€57,220
2021
€45,925
Average result
€70,998
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€507,129 / €591,650 / €709,980

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 21 November 2026 via checked.be.